Insulin gene transfer can be a new optional therapy for replacement of pancreas.
Kuzume
M
M
Department of Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yamaguchi
M
M
Matsumoto
T
T
Matsumiya
A
A
Shimura
H
H
Nakano
H
H
Kumada
K
K
Takeda
M
M
D000256:Adenoviridae; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D002460:Cell Line; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D004285:Dogs; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000096:biosynthesis / Q000235:genetics* / Q000627:therapeutic use; D010180:Pancreatectomy; D011384:Proinsulin / Q000096:biosynthesis / Q000235:genetics*; D011498:Protein Precursors / Q000096:biosynthesis / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis; D014162:Transfection / Q000379:methods*
D001786:Blood Glucose; D002096:C-Peptide; D007004:Hypoglycemic Agents; D007328:Insulin; D011498:Protein Precursors; D011994:Recombinant Proteins; C013737:preproinsulin; D011384:Proinsulin